Deck
eClerx Services · ECLERX · NSE
eClerx is a Mumbai-based knowledge-process and data-analytics outsourcer that runs data management, analytics and automation for global banks, asset managers and technology firms, billing almost entirely in US dollars.
₹1,556
Share price
₹14,300 cr
Market cap
₹4,217 cr
FY2026 revenue
27.6%
Return on equity
Public since 2007; the stock bottomed near ₹354 in the March-2020 COVID selloff and compounded to a pre-bonus high around ₹4,950 in February 2026. A 1-for-1 bonus in March 2026 mechanically halved the quote to about ₹1,576, and it trades near ₹1,556 today — roughly ₹3,100 on a bonus-adjusted basis.
2 · The central tension
The margin recovery is real — but roughly half of it is a weak rupee, not operating leverage
- The arc. Operating margin peaked near 26% in FY2022, when COVID suppressed travel and facility costs, ground down to about 20% by FY2025 as costs normalised and onshore Personiv work diluted the mix, then recovered to 21% in FY2026.
- Half is currency. Management's own Q2 FY2026 walk pinned 200 of a 400-basis-point sequential EBITDA jump on FX and only about 60 bps on delivery — so the print flatters the underlying rate, and the gain reverses if the rupee firms.
- The durable lever is utilisation. The genuinely repeatable piece ran to an eight-quarter high of 76.5% in Q3 before easing to 74% in Q4 FY2026; whether it holds there, not where the rupee goes, decides if margins have truly troughed.
Strip out the rupee and revenue compounds in the high-teens, not the 22% headline — strong for a BPM operator, but softer than the reported number implies.
3 · The financial state
A debt-free compounder that turns essentially all profit into cash — at the cohort's lowest multiple
₹4,217 cr
FY2026 revenue
+22% YoY
₹754 cr
Free cash flow
over 100% of net profit
27.6%
Return on equity
top of its cohort
~20x
Trailing P/E
lowest in the peer group
eClerx is a people business — staff is about 61% of revenue, capex under 3% — so profit swings on utilisation and the rupee, but the cash is unambiguous: zero interest-bearing debt, roughly ₹697 cr of net cash, and free cash flow of ₹754 cr that exceeded ₹706 cr of net profit in FY2026. The market discounts the stock to about 20x — below Firstsource, Datamatics and LatentView at 25–31x — pricing client concentration and the FX-flattered margin, not a flaw in the accounts.
4 · Ownership and governance
Founder-controlled at ~54%, but the promoters behave like owners, not extractors
- A stable, unpledged stake. Co-founders PD Mundhra and Anjan Malik have held a rock-steady 53–54% across FY2021–FY2025 with zero shares pledged in any year, and they handed day-to-day control to a salaried Group CEO installed in 2023.
- Cash goes to everyone, pro-rata. Dividends are strictly per-share, insider pay is small and falling — Mundhra's dropped from ₹2.76 cr to ₹1.71 cr and Malik draws no salary — and surplus is returned through equal-terms tender buybacks; recurring promoter-directed cash runs under 0.3% of revenue and has fallen to about 0.13%.
- Clean books. Five consecutive unqualified audits; the FY2025 switch from S.R. Batliboi to PwC was a scheduled statutory rotation disclosed a year ahead, not a suspicious churn near a qualification.
The one real caveat is concentration of a different kind — about 54% of the register sits with two people, so governance rests on their continued conduct.
5 · The other side of growth
The growth engine is a concentrated set of US clients — its strength and its main risk
- North America is about three-quarters of revenue and the mix has tilted further toward it over the decade, so durable 20%+ growth rests on a concentrated base of anchor US financial-services and technology accounts.
- But concentration is easing at the top. Top-10 client share fell to 59% in Q4 FY2026 from 63–64%, and the alarming-looking 34% FY2026 EPS decline is a 1-for-1 bonus artefact — net profit actually rose 30%.
- Watch the cash-quality tell. Trade receivables rose to about ₹1,014 cr from ₹790 cr and DSO spiked from 80 to 86 days in Q1 FY2026 on client billing-system changes before settling around 80 — the fastest early-warning gauge for a business this cash-generative.
6 · The picture
Best-in-cohort quality at the cohort's lowest price — with the margin and the mix still on probation
- What supports it. Durable 20%+ revenue growth, ~28% ROE, a genuinely debt-free balance sheet, 100%+ cash conversion feeding steady buybacks, and clean, owner-aligned governance — all at the cheapest multiple in its quality cohort.
- What cuts against it. About half the FY2026 margin recovery is a weak-rupee tailwind that reverses if the rupee firms, roughly 75% North America concentration keeps growth quality on probation, and about 80% of receivables are hedged, capping further FX upside.
- The swing factor. Whether utilisation and delivery mix — not currency — can hold the EBITDA margin near the company's roughly 25% target is what separates a genuine operating-leverage story from an FX mirage.
Watchlist to re-rate: EBITDA margin ex-currency (can utilisation, not the rupee, hold it near 25%?); receivables and DSO as the cash-quality gauge; and the board-independence ratio, which has slipped from about 78% to 67%.